Physician and executive reviewing healthcare operational evidence
    Financial & Policy Intelligence

    FY 2027 IPPS Revenue & Mandatory Episode Exposure Assessment

    A facility-specific assessment translating CMS-1849-F into the payment, rural-policy, new-technology, quality, and mandatory CJR-X exposures that matter to the organization.

    Request FY 2027 IPPS Assessment

    Who it's for

    Hospital and health-system CFOs, revenue integrity and revenue cycle leaders, rural hospital executives, orthopedic/service-line leaders, and CMO/quality leaders.

    Based on

    The FY 2027 IPPS/LTCH final rule, CMS impact files, CJR-X model materials, applicable rural-payment status, organization-supplied operating context, and relevant service-line data.

    Why it matters

    The national 2.3% rate update is not a hospital forecast. Wage index, DSH and uncompensated care, quality, outliers, case mix, rural eligibility, new-technology capture, and episode performance can move the facility result in different directions.

    What we analyze

    Provider-level payment impact; DSH/uncompensated-care exposure; MDH/low-volume extension versus expiration scenarios where applicable; NTAP capture opportunities; TEAM/CJR-X participation and 90-day episode exposure; quality and electronic prior authorization readiness.

    What you receive

    A hospital-specific payment-driver bridge, exposure findings, prioritized executive action plan, and executive findings session.

    Format

    Executive exposure assessment.

    Discuss this engagement

    Tell us about the organization and the decision you are facing. We will confirm the scope before work begins.